A theme focused on maintaining a stable supply of products by strengthening BCP measures and production capabilities to fulfill the supply responsibility of a medical device manufacturer. It includes specific production plans for manufacturing sites, such as the start of mass production of JIZAI at the Hanaoka Plant.